CLINICAL_TRIALS
trial_result
· 2020-05-01
Clinical Trial Update: Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia [Phase 1, Phase 2]
Summary
A midostaurin and azacitidine trial in elderly patients with untreated acute myeloid leukemia completed phases 1 and 2 with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brenda Cooper, MD | Conditions: Untreated Adult Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-01